1. Introduction {#s0005}
===============

Seizures and status epilepticus carry a high risk of morbidity and mortality. A large seizure burden is associated with unfavorable outcomes after hospitalization; in some settings, every additional hour of seizure recorded on EEG increases the risk of later disability and mortality ([@b0065], [@b0180]). Therefore, recognition of seizures and EEG patterns strongly associated with seizures, is vitally important.

Some EEG patterns are recognizably ictal (i.e., patterns with clinical and EEG improvement after IV AED, epileptic discharges occurring at \>2.5 Hz, or those with typical spatiotemporal evolution ([@b0020])), and some are clearly non-ictal. However, neurophysiologists frequently encounter more ambiguous patterns, with periodic discharges or rhythmic activity found in more than one-third of patients undergoing continuous EEG monitoring in a large multicenter database ([@b0165]). This activity lies on a spectrum now known as the "ictal-interictal continuum ([@b0035])" ([Fig. 1](#f0005){ref-type="fig"}). These patterns present a challenging management situation, especially in comatose patients.Fig. 1Quantitative ictal-Interictal Continuum. This figure (inspired by [@b0035]) shows the reported relative association with seizures and published mortality of patterns on the ictal-interictal continuum. On the x-axis is increasing association with seizures; on the y-axis is increasing mortality. LPDs = lateralized periodic discharges; BIPDs = bilateral independent periodic discharges; GPDs = generalized periodic discharges; LRDA = lateralized rhythmic delta activity; GRDA = generalized rhythmic delta activity; SIRPIDs = stimulus-induced rhythmic, periodic, or ictal discharges. Mortality rates not available for GRDA and LRDA.

We will review here the prevalence, etiologies, and outcomes of these patterns ([Table 1](#t0005){ref-type="table"}), as well as an approach to treatment.Table 1Reported etiologies, association with seizures, and mortality of periodic and rhythmic patterns.FeatureCommon causesAssociation with seizuresMortalityLateralized Periodic Discharges (LPDs)Stroke\
Tumor\
InfectionHemorrhage50--100%24--41%Bilateral Independent Periodic Discharges (BIPDs)Stroke\
Anoxic injury\
Metabolic disordersInfection\
Tumors43--78%39--100%Generalized Periodic Discharges (GPDs)Metabolic\
Sepsis\
AnoxicStroke29--50%30--64%Lateralized Rhythmic Delta Activity (LRDA)Hemorrhage\
Stroke\
TumorTBI\
Infection25--63%Generalized Rhythmic Delta Activity (GRDA)Encephalopathy\
Stroke\
HemorrhageTumor\
Infection\
Drug inducedNo additional association with seizures compared to controls without GRDAStimulus-Induced Rhythmic, Periodic, or Ictal Discharges (SIRPIDs)Hemorrhage\
Anoxic injury\
Drug toxicityMetabolic\
TBI27--51%\
One large study found no increase in seizures when features had stimulus-induced compared to spontaneous patterns17%

2. Lateralized periodic discharges (LPDs) {#s0010}
=========================================

2.1. Definition {#s0015}
---------------

The discharges formerly known as "PLEDs" (periodic lateralized epileptiform discharges), lateralized periodic discharges (LPDs) are unilateral, relatively uniform discharges (often with sharp or spike morphology), typically ranging from 100--300 uV ([@b0230]), recurring at regular intervals up to 3 per second, with a clear return to baseline between adjacent discharges ([@b0130]) ([Fig. 2](#f0010){ref-type="fig"}) .Fig. 2An example of right-sided lateralized periodic discharges (LPDs) in a 70-year-old woman with CNS lymphoma. Note the fast component with LPDs, which may be termed LPDs + F (LPDs plus fast).

2.2. Prevalence {#s0020}
---------------

LPDs are a relatively uncommon finding in the general population. In unselected patients undergoing EEG (including outpatients), the prevalence of LPDs is 0.4--1% ([@b0085], [@b0190]). In hospitalized patients undergoing continuous EEG monitoring, the prevalence is 6.2%--8.6% ([@b0165], [@b0240], [@b0260]). Periodic patterns tend to flock together: LPDs are also seen in 21.5% of patients with generalized periodic discharges (GPDs) undergoing prolonged cEEG monitoring ([@b0090]).

2.3. Etiologies {#s0025}
---------------

The most common causes of LPDs are stroke, infection, tumor, and hemorrhage ([@b0085], [@b0105], [@b0115], [@b0275]), and LPDs can be seen after either an acute insult or in the setting of a chronic condition ([@b0225]). Intracranial hemorrhage commonly produces LPDs (particularly when involving the cortex), and LPDs occur in 13% of these patients ([@b0050]).

Most often, LPDs arise from dysfunction in both the cortical gray and subcortical white matter ([@b0115], [@b0225]), but periodic discharges including LPDs can also occur in the setting of toxic or metabolic insult, even in the absence of a focal lesion ([@b0085], [@b0105]).

2.4. Association with seizures {#s0030}
------------------------------

LPDs are often temporally associated with clear-cut seizures. Depending on the study, the incidence of clinical or electrographic seizures in the setting of LPDs is 50--100% ([@b0105], [@b0110], [@b0190], [@b0260]). The question of whether LPDs themselves represent ictal patterns is debated; when focal twitching or movements are time-locked to a discharge, LPDs are considered ictal ([@b0275]); clear focal motor seizures including epilepsia partialis continua (EPC) may be time- and location-correlated to observed LPDs ([@b0085]). However, in a study of with and without motor manifestations, Sen-Gupta et al. found that LPDs with associated motor findings were more likely to arise from central head regions, and concluded that motor findings are not a reliable determinant of whether LPDs are "ictal" or "non-ictal." They argue that LPDs occurring in other locations would be expected to have other clinical manifestations (such as confusion or aphasia), or to be asymptomatic ([@b0240]), and that LPDs without motor manifestations may also be ictal patterns.

LPDs have been further differentiated based on associated morphology: In 1991, Reiher et al. drew a distinction between PLEDs associated with brief, stereotyped rhythmic discharges, termed "PLEDs plus", and PLEDs without rhythmic discharges, termed "PLEDs proper" ([@b0200]). Seizures and status epilepticus were significantly more likely to be seen in patients with PLEDs plus (74% of patients) than with PLEDS proper (6% of patients). "PLEDs plus" as a high-risk group for seizures has been confirmed subsequently ([@b0085]), most recently in a large multicenter study of 4772 patients undergoing cEEG. Patients with LPDs-plus had a significantly higher association with seizures than did patients with LPDs alone, with odds ratios of 13.35 and 6.68 respectively ([@b0215]).

LPDs with superimposed fast or rhythmic characteristics are more likely to respond to medication: in one series, the 7 of 23 patients who showed clinical and EEG improvement after receiving AEDs for LPDs all had "LPDs plus" ([@b0185]).

The frequency of LPDs also provides information about their association with seizures: while LPDs at any frequency carry a risk of seizures, the risk increases with higher frequencies, reaching an odds ratio of 16.4 for LPDs \>2 Hz ([@b0215]).

2.5. Imaging and supportive tests {#s0035}
---------------------------------

Metabolic imaging with SPECT during LPDs has been reported to show hypoperfusion ([@b0135]) in some cases, leading to more conservative treatment, or hyperperfusion ([@b0040]) in others, which may influence more aggressive treatment, as increased blood flow on SPECT is a sensitive marker for ictal activity in patients with epilepsy ([@b0070]).

FDG-PET also may show hypermetabolism or hypometabolism in the region of LPDs, and may change from hypermetabolic to hypometabolic during a patient's course as LPDs resolve ([@b0040], [@b0120]). This may represent the changing nature of LPDs during hospital course, though hyper- or hypometabolism could also reflect recent seizures prior to imaging or surrounding brain injury.

In a study of patients with periodic discharges who also received FDG-PET, 9 patients with LPDs had PET, of which 7/9 (77.8%) had focal hypermetabolism ([@b0250]); in 8/9 (including all with hypermetabolism), the pattern was thought to represent electrographic or electroclinical status epilepticus based on motor correlate or response to medication.

On MRI, the degree of ADC change correlates to neuronal cell loss in animal studies ([@b0075]); ADC changes and restricted diffusion is seen after SE. One small series of 10 patients with LPDs (5 with seizures and 5 without) found that patients with LPDs only had no evidence of restricted diffusion ([@b0170]), which suggests that LPDs do not produce the same degree of neuronal injury as do seizures.

Neuron-specific enolase (NSE), a marker of brain injury, is elevated after both convulsive and non-convulsive seizures ([@b0195]), but has not yet been widely used in patients with periodic or rhythmic patterns. NSE levels did not rise despite ongoing LPDs in one reported patient ([@b0040]).

2.6. Outcomes {#s0040}
-------------

LPDs have a significant association with increased mortality. The mortality of patients with LPDs ranges from 24--41% ([@b0085], [@b0225], [@b0275]), with a "poor" outcome in 68% ([@b0240]) and only 21% achieving independent functional status after 1 year ([@b0225]).

The underlying etiology of LPDs greatly influences outcome ([@b0275]). Patients with an underlying neoplasm have higher rates of functional dependence after one year compared to those with a vascular etiology ([@b0225]). In one study of 79 patients with LPDs, the risk of death was lower when LPDs were due to chronic etiology versus an acute etiology (OR 0.14, 95% CI 0.03--0.72). In addition, the risk of death was lower when LPDs had associated seizures than in LPDs without seizures (OR 0.21, 95% CI 0.04--0.97) ([@b0225]). However, patients with status epilepticus who had LPDs following resolution of status have higher mortality than those who did not (40% mortality in patients with LPDs) ([@b0145]).

A case-control study of 37 patients with LPDs, age and etiology-matched to control patients, found that LPDs were significantly associated with worsened outcome, seizures, and impairment of consciousness, even in the absence of acute brain injury ([@b0220]). Patients with intracerebral hemorrhage have a worse prognosis when LPDs are present (OR 10.1 for poor outcome with LPDs ([@b0050])). In patients with poor-grade subarachnoid hemorrhage, the presence of LPDs is highly associated with a worse outcome (OR 18.8 for poor outcome) ([@b0045]).

Interestingly, there is some evidence that patients with isolated periodic discharges (PDs) are more likely to die than are to those with PDs who do have seizures on EEG. One study found an odds ratio for death of 0.21 in patients with PDs and seizures compared to those with PDs alone ([@b0225]); this may reflect more severe injury in those with PDs in isolation, or may reflect a transient or less severe nature of PDs associated with seizures.

In patients without a history of seizures prior to hospitalization, the majority of those with LPDs go on to have later seizures (56%--67% of patients) ([@b0235], [@b0275]).

In most cases, LPDs are an acute and transient finding, resolving after 8--10 days ([@b0085], [@b0105]). LPDs may in fact be seen in a stage of untreated prolonged status epilepticus, following continuous ictal activity ([@b0265]). They may represent an acute phase of the healing process or a stage in the recovery (or path to) seizures, resolving by 2 weeks after the acute event. However, in rare instances LPDs will be a chronic finding, and have been observed chronically in asymptomatic patients for up to 20 years ([@b0285]).

3. Bilateral independent periodic discharges (BIPDs) {#s0045}
====================================================

3.1. Definition {#s0050}
---------------

Rarer than their related cousin LPDs, BIPDs may carry a poorer prognosis. BIPDs are asynchronous, repetitive, independent left and right hemispheric discharges, often with a sharp or spike morphology, typically ranging from 100--300 uV ([@b0230]), which recur at regular intervals up to 3 per second, with a clear period between adjacent discharges ([@b0130]) [Fig. 3](#f0015){ref-type="fig"}).Fig. 3An example of bilateral independent periodic discharges (BIPDs) in a 68-year-old woman with scleroderma and HSV encephalitis.

3.2. Prevalence {#s0055}
---------------

BIPDs are far less common than LPDs; only 0.2% of unselected patients undergoing EEG have BIPDs ([@b0085]). In a large, multicenter study of all patients undergoing continuous EEG monitoring, BIPDs were present in 0.4% of patients (and in only 4% of those with epileptiform discharges) ([@b0165]); other studies have reported BIPDs in 3.5% of critically ill patients undergoing cEEG ([@b0055]). Etiology matters: BIPDs are seen in 9.5% of patients with CNS infection ([@b0030]), but in only 1% of patients with intracerebral hemorrhage ([@b0265]). BIPDs may also keep company with other periodic discharges, found in 10.5% of patients with GPDs ([@b0090]); patients may also have only unilateral LPDs at other times ([@b0085]).

3.3. Etiologies {#s0060}
---------------

BIPDs are usually found in settings of acute and subacute injury, rather than chronic conditions ([@b0225]). The most common causes reported are infections, anoxic injury ([@b0060]), stroke, tumors ([@b0225]), and metabolic disorders ([@b0185]); more rare causes include Hashimoto's encephalitis ([@b0085]) and lupus ([@b0015]).

3.4. Association with seizures {#s0065}
------------------------------

BIPDs also have a high association with seizures, which are reported in 43--78% of patients with BIPDs ([@b0060], [@b0085], [@b0225]); 100% association with seizures was seen in 4 patients with BIPDs and CNS infection ([@b0030]). Patients with BIPDs often have a poor neurologic exam, and 48% are comatose (compared to 17% of patients with LPDs). Focal neurologic findings on exam are rare ([@b0225]); however, focal unilateral and bilateral independent focal motor activity has been reported with over half the patients with BIPDs ([@b0085]).

3.5. Imaging {#s0070}
------------

In one study, focal findings on imaging were less common in patients with BIPDs (25%) compared to LPDs (74%) ([@b0185]). Similar to LPDs, the majority of patients with BIPDs have both cortical and subcortical abnormalities ([@b0225]).

Fewer cases of metabolic imaging have been published in patients with BIPDs than with LPDs. One patient with lupus and BIPDs in the frontal regions and underlying white matter disease had reduced blood flow in the areas of BIPDs on SPECT ([@b0015]); reduced blood flow with BIPDs has been reported in one other case ([@b0100]).

3.6. Outcomes {#s0075}
-------------

BIPDs have been thought of as a marker of more severe disease and as an indicator of worse prognosis than LPDs. The reported mortality ranges from 39--100 ([@b0185], [@b0225]).

The largest comparisons of BIPDs to LPDs have shown higher mortality in BIPDs. De la Paz et al. found a 61% mortality in 18 patients with BIPDs, more than twice the 29% found in the 45 patients with LPDs([@b0060]). In a retrospective study of 21 patients with BIPDs, the mortality was 52%, much higher than the overall mortality rate of patients with LPDs (27%) ([@b0085]). In a separate study including 23 patients with BIPDs, 39.1% had a fatal outcome, while only 21.7% had an independent recovery; this was significantly worse than the 24--29% mortality in patients with LPDs and GPDs ([@b0225]).

Rare cases of long-term, "benign" BIPDs are reported ([@b0100]).

4. Generalized periodic discharges (GPDs) {#s0080}
=========================================

4.1. Definition {#s0085}
---------------

GPDs at first appear closely related to LPDs and BIPDs; however, metabolic illnesses more commonly give rise to GPDs. GPDs are bilaterally synchronous, repetitive discharges (often with a sharp or spike morphology), typically with amplitudes \>100 uV, repeating at regular intervals at up to 3 per second, with a clear period between adjacent discharges ([@b0130]) ([Fig. 4](#f0020){ref-type="fig"}).Fig. 4An example of generalized periodic discharges (GPDs) in a 54-year-old man with sepsis and renal failure.

4.2. Prevalence {#s0090}
---------------

A large review of 3064 patients undergoing cEEG found GPDs in 138 (4.5%) ([@b0090]); other studies have found a much lower prevalence, from 0.8--1.8% ([@b0165], [@b0260]). GPDs often coexist with LPDs.

4.3. Etiologies {#s0095}
---------------

The majority of patients with GPDs have a toxic-metabolic illness or sepsis, and many have coexisting brain injury as well ([@b0090], [@b0140], [@b0225], [@b0290]). GPDs were present in only 6% of patients with intracerebral hemorrhage in one study ([@b0050]). Compared to LPDs, an acute insult (rather than a chronic injury) is more common with GPDs ([@b0225]). Patients with GPDs are usually comatose or stuporous, comatose 70% of the time in one study ([@b0090], [@b0225]).

4.4. Association with seizures {#s0100}
------------------------------

The rates of seizures with GPDs are significant though not quite as high as the seizure rates of BIPDs and LPDs. The largest series report the incidence of seizures with GPDs as between 29--50% ([@b0090], [@b0225], [@b0260]), and these are often nonconvulsive. In a case-control study of 200 patients on cEEG with GPDs and 200 without, seizures were much more prevalent in the GPD group (46%) compared to the controls (34%) ([@b0090]). An even greater difference was seen in the rates of patients with nonconvulsive status epilepticus (NCSE): 22% of the patients with GPDs had NCSE, compared to 7% of controls. Higher rates of concomitant seizures are seen with higher frequencies of GPDs; while GPDs \<1.5 Hz were not significantly associated with seizures in one large multicenter study, GPDs occurring at 1.5--2 Hz had an odds ratio of 2.3 for association with seizures and of 3.3 at high frequencies (≥2 Hz) ([@b0215]).

4.5. Imaging {#s0105}
------------

Similar to the other periodic findings described, a combination of subcortical and cortical injuries are common in GPDs ([@b0290]), though isolated subcortical lesions are present in 30% ([@b0225]).

PET is less commonly reported in patients with GPDs than with LPDs. Three of 5 patients with GPDs had hypermetabolism on PET ([@b0250]); each of the 3 with hypermetabolism had concern for electrographic or electroclinical status epilepticus based on response to medications or other clinical findings.

4.6. Outcomes {#s0110}
-------------

The mortality in patients with GPDs is quite high: 30%--64% ([@b0090], [@b0140], [@b0225]). A poor outcome has been seen in 51.5% in one study ([@b0090]), and only 18% reached an independent functional capacity at one year of follow up ([@b0225]). However, some mortality may be due to the frequently coexisting seizures, and mortality is related to underlying etiology: in one large study, after controlling for the presence of seizures (which predict worse outcome), patients with GPDs did not have a worse outcome than were controls matched by age and etiology ([@b0090]).

4.7. Triphasic waves {#s0115}
--------------------

A subtype of GPDs with "triphasic morphology" were first described in the 1950 s ([@b0150]). Triphasic morphology refers to "repetitive electrographic elements consisting of three phases, each longer than the preceding one: a surface positive high-amplitude (\>70 uV) wave preceded and followed by negative waves with smaller amplitude" ([@b0255]). However, accurately identifying triphasic waves is challenging: one study of 11 cEEG reviewers assessing 20 samples of GPDs found only fair inter-rater agreement (κ = 0.33) in whether or not GPDs had a triphasic morphology ([@b0095]).

Traditionally described with hepatic insufficiency, triphasic waves (TWs) have been strongly associated with liver and multi-organ failure, especially at high levels of urea and ammonia ([@b0255]). However, TWs are also seen in other scenarios such as hypernatremia, hypothyroidism, sepsis, lithium toxicity, and hypertensive encephalopathy ([@b0080], [@b0150]). One recent study of GPDs found that those with triphasic morphology were just as likely to be associated with seizures as were GPDs without ([@b0095]).

In a large series of patients with encephalopathy, Sutter et al. found that patients with TWs have a high mortality rate (OR 4.5 for in-hospital death) ([@b0255]).

5. Lateralized rhythmic delta activity (LRDA) {#s0120}
=============================================

5.1. Definition {#s0125}
---------------

Less clearly related to the periodic patterns, lateralized rhythmic activity carries a similar risk of seizures to its periodic cousins, LPDs. LRDA is a unilateral repetitive waveform, with nearly uniform duration and morphology, recurring at up to 3 Hz without a measurable inter-waveform interval([@b0130]) ([Fig. 5](#f0025){ref-type="fig"}). LRDA tends to occur in shorter runs (often lasting less than one minute) than do LPDs([@b0110]).Fig. 5An example of right-sided lateralized rhythmic delta activity (LRDA) in a 64-year-old man with right middle cerebral artery stroke. Note the abnormal EKG rhythm as well.

5.2. Prevalence {#s0130}
---------------

One series found LRDA in 27/558 (4.7%) of acutely ill patients on continuous EEG monitoring ([@b0110]); a large proportion (44%) of these cases are also associated with LPDs ([@b0110]).

5.3. Etiologies {#s0135}
---------------

The most common conditions for LRDA reported are intracerebral and subarachnoid hemorrhages; other conditions include stroke, tumor, traumatic brain injury, and infection ([@b0110]). A high proportion (70%) of patients with LRDA have a focal abnormality on neurologic examination, concordant with the side of LRDA ([@b0110]).

5.4. Association with seizures {#s0140}
------------------------------

One study found seizures in the majority of patients with LRDA ([@b0110]), most of which were nonconvulsive. In that study, the rate of seizures was even higher in patients with LRDA (63%) than with LPDs (57%) ([@b0110]).

Similarly to LPDs and GPDs, faster rates of LRDA have a higher risk of associated seizures. Rodriguez-Ruiz et al. found that LRDA is associated with seizures in 25--44% of patients, with a higher risk of seizures seen at higher frequencies (significant associations found at rates of 1.5--2 Hz (OR 1.8) and ≥2 Hz (OR 4.0); [@b0215]).

5.5. Imaging {#s0145}
------------

LRDA is frequently seen in lesions involving cortex or subcortical white matter ([@b0110]); nearly all patients with LRDA have focal injury on the side of the rhythmic activity. Patients with LRDA more commonly have a focal lesion involving the cortex than do patients with nonrhythmic focal slowing ([@b0110]).

5.6. Outcome {#s0150}
------------

To date, no studies have reported the outcome of patients with LRDA, though it may be similar to that of patients with LPDs given the similar association with seizures.

6. Generalized rhythmic delta activity (GRDA) {#s0155}
=============================================

6.1. Definition {#s0160}
---------------

Perhaps the most benign inhabitant of the ictal-interictal zone, GRDA is a bilateral, bisynchronous and symmetric repetitive waveform, often \>100 uV in amplitude, with nearly uniform duration and morphology recurring at up to 3 Hz (without a measurable inter-waveform interval) ([@b0130]) ([Fig. 6](#f0030){ref-type="fig"}). Prior to the ACNS guidelines for terminology standardization in 2012, the term frontal intermittent rhythmic delta activity (FIRDA) was frequently used, as GRDA is commonly maximal in the frontal regions.Fig. 6An example of generalized rhythmic delta activity (GRDA) in a 79-year-old man with sepsis.

6.2. Prevalence {#s0165}
---------------

GRDA was reported in 16.1% of patients undergoing continuous EEG monitoring in one large study of 4772 patients ([@b0215]); observed rates reported for FIRDA in unselected patient groups are 0.6--6% ([@b0005], [@b0280]).

6.3. Etiologies {#s0170}
---------------

When described as FIRDA, the most common etiologies have been reported to be brain tumor surgery and cerebrovascular diseases ([@b0160], [@b0255]). In one series, the majority (55%) of patients had a structural lesion, while an infectious condition, renal disease, or sedative medication were commonly associated ([@b0005]).

6.4. Association with seizures {#s0175}
------------------------------

A large, multicenter study of 1513 critically ill patients with periodic or rhythmic activity found that GRDA was not associated with an increased risk of seizures, even at higher frequencies (\>2 Hz) or when accompanied by sharp morphology ([@b0210]).

However, in certain patient groups, GRDA may have a different implication. Patients with NMDA encephalitis often have GRDA or GRDA with overlying fast activity, known as "extreme delta brush;" GRDA and EDB are argued to represent ictal patterns in these patients.

6.5. Imaging {#s0180}
------------

Although GRDA and FIRDA are bilateral or generalized patterns, the underlying brain lesion (when present) is more frequently lateralized than midline (lateralized in 77% of cases) ([@b0005]).

One of 4 patients (25%) with GRDA who underwent FDG-PET had focal hypermetabolism on PET; in the one patient with hypermetabolism, there was concern for electrographic status epilepticus based on \>3 Hz frequency of GRDA at times ([@b0250]). The patients with frequency of GRDA \<3 Hz had no hypermetabolism.

6.6. Outcome {#s0185}
------------

The outcome after GRDA is related to the underlying etiology. Outcomes after FIRDA are relatively good, with 69% of patients with FIRDA returning home after hospital discharge in one study ([@b0255]).

7. Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs) {#s0190}
=====================================================================

7.1. Definition {#s0195}
---------------

A special subtype of patterns in the ictal-interictal continuum, SIRPIDs are rhythmic, periodic, or ictal-appearing patterns consistently elicited by stimulation of the patient (i.e. suctioning, noise, or physical examination of the patient) ([@b0125]) ([Fig. 7](#f0035){ref-type="fig"}). The stimulus-induced nature may be indicated by adding "SI" to a following term such as SI-GPDs or SI-LRDA under the ACNS standardized terminology guidelines ([@b0130]). However, as SIRPIDs are studied separately in a number of publications ([@b0010], [@b0025]), we will consider these stimulus-induced patterns together.Fig. 7An example of stimulus-induced generalized periodic discharges (SI-GPDs) evolving to generalized rhythmic delta activity (GRDA) in a 68-year-old woman with tuberculosis meningitis.

7.2. Prevalence {#s0200}
---------------

SIRPIDs are a relatively common phenomenon in the critically ill, found in 10--34% of patients undergoing EEG monitoring ([@b0025], [@b0125], [@b0175]).

7.3. Etiologies {#s0205}
---------------

SIRPIDs also stem from many etiologies, the most common being intracerebral hemorrhage, anoxic brain injury, metabolic disturbances, traumatic brain injury, and drug toxicity ([@b0025], [@b0125], [@b0270]).

7.4. Association with seizures {#s0210}
------------------------------

Most studies report a strong association of SIRPIDs with seizures, with 27--51% of patients found to have coexisting spontaneous seizures ([@b0025], [@b0125]) (and 4/4 patients with SIRPIDs had NCSE in one small study) ([@b0270]). However, the largest series of patients on cEEG monitoring found no increased association of seizures in patients with stimulus-induced compared to spontaneous patterns ([@b0215]). When present, focal seizure onset locations often have no relation to the location of focal SIRPIDs ([@b0125]).

7.5. Imaging {#s0215}
------------

In the three reports of patients with SIRPIDs who received SPECT, there was no increase in cerebral blood flow during SIRPIDs ([@b0245], [@b0295]). This included one patient with motor weakness during the discharges ([@b0295]), and has been taken as evidence to support more conservative management rather than aggressive treatment to suppress SIRPIDs.

7.6. Outcomes {#s0220}
-------------

Focal SIRPIDs have been associated with a poor outcome when present in patients with intracerebral hemorrhage ([@b0050]). When present after cardiac arrest, SIRPIDs seen during the hypothermia period (but not during normothermia) are associated with increased mortality; patients with SIRPIDs were also more likely to have a discontinuous EEG background (a known poor predictive feature) ([@b0010]). SIRPIDs were more commonly seen in patients who died in the hospital than in patients who survived in one study; however, after adjusting for EEG reactivity, age, and anoxic brain injury, SIRPIDs were independently associated with increased mortality ([@b0025]).

8. Treatment approach {#s0225}
=====================

No clear guidelines exist for how to treat these ictal-interictal rhythmic and periodic patterns. However, management can be tailored to the on the clinical scenario and supportive studies (when available). Increased seizure burden is associated with worse outcome in particular patient populations ([@b0065], [@b0180]); as some periodic and rhythmic patterns are highly associated with seizures, the case for treatment is strong.

If periodic patterns correspond to clinical signs such as motor activity, the case for treating with AEDs is strong; when found in a comatose patient or patient with altered mental status but no motor signs, the need for aggressive treatment is less clear. Seizure prophylaxis with one AED is usually reasonable, but how aggressively should the clinician treat ongoing LPDs? The underlying etiology of the patient's disease, the comorbidities and resuscitation status of the patient, and overall prognosis (independent of the EEG pattern) all must play a role in the decision whether or not to aggressively treat or suppress periodic discharges. Supportive studies such as PET or SPECT may help clarify the need for treatment ([@b0040]). When patterns are of unclear significance, nonsedating AEDs should be used preferentially, and the patient's clinical status taken into account to avoid the need for intubation. If the patient can tolerate a benzodiazepine, a trial of intravenous (IV) benzodiazepine may help clarify the significance of the pattern (if there is a clinical and/or electrographic improvement), but continuous IV medications are not recommended for these unclear patterns.

Most seizures occur within 24 h of cEEG ([@b0260]), but in some high-risk populations such as intracerebral hemorrhage, more than one-fourth of seizures occur after the first 24 h ([@b0050]). When high-risk periodic or rhythmic patterns are seen, monitoring for at least 24--48 h to assess for seizures is reasonable.

We therefore suggest the following approach to treatment of patterns on the ictal-interictal continuum -- see [Fig. 8](#f0040){ref-type="fig"} (modified from Rodriguez ([@b0205]) and Claassen ([@b0040])):1)Assess for clinical correlation to the rhythmic or periodic pattern and if present, treat with an (additional) AED.2)Assess for any of the high-risk characteristics: LPDs, LRDA, BIPDs, or SIRPIDs with "plus" characteristics (sharp, fast, or rhythmic activity), or LRDA \> 2 Hz; if present, treat with an (additional) AED or perform benzodiazepine trial, and monitor for additional 24--48 h; continue treatment if there is clinical and EEG improvement.If GPDs with high risk characteristics (\>2 Hz, or additional rhythmic or fast activity) are present: assess for underlying toxic-metabolic abnormality and if found, monitor 24--48 h; if no toxic-metabolic etiology is present, treat with an (additional) AED, or perform benzodiazepine trial to assess for clinical improvement.3)If LPDs, LRDA, BIPDs, GPDs, or SIRPIDs without high-risk characteristics are present, monitor for an additional 24--48 h to assess for clinical or EEG worsening, or clear electrographic seizure activity (and treat with AED if found).4)If there is uncertainty regarding clinical correlation or response to treatment, additional testing with functional imaging (SPECT or PET) when available is recommended; increased blood flow with the rhythmic or periodic pattern supports treatment.5)For GRDA, no increased risk of seizures has been found; in the absence of clinical correlation, usually no treatment is advised (the exception may be NMDA encephalitis ([@b0155])).Fig. 8Suggested algorithm for approach to patterns on the ictal-interictal continuum. AED = antiepileptic drug; LPDs = lateralized periodic discharges; BIPDs = bilateral independent periodic discharges; GPDs = generalized periodic discharges; LRDA = lateralized rhythmic delta activity; GRDA = generalized rhythmic delta activity; SIRPIDs = stimulus-induced rhythmic, periodic, or ictal discharges; TM = toxic-metabolic.

9. Concluding remarks {#s0230}
=====================

Denizens of the ictal-interictal continuum are challenging to encounter and must be carefully evaluated to determine whether high-risk features occur. In most cases, prolonged (24--48 h) monitoring is warranted, as is empiric AED treatment for some high-risk patterns. Functional imaging may help determine the significance of the pattern if clinical correlation and EEG response to treatment are ambiguous.
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